Literature DB >> 908039

Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice.

D D Mickey, K R Stone, H Wunderli, G H Mickey, R T Vollmer, D F Paulson.   

Abstract

Nude mice of NIH/Swiss background were utilized for the heterotransplantation of a tissue culture cell line derived from a human prostate adenocarcinoma metastatic to the brain. These cells, which had been grown in vitro for 13 passages, formed solid tumors when injected s.c. into nude mice. The cell line DU 145 has been passaged 60 times in vitro over a period of 18 months. Tumors removed from the mice were serially transplanted to additional mice and reestablished in vitro. Light-microscopic analysis of the tumor grown in nude mice revealed a strong similarity to the patient's metastatic tumor. The ultrastructure of the tumor cells propagated in nude mice was compared to that of the original human tumor cells and to the tissue culture cells, both before and after passage in nude mouse. No major differences were detected. Karyotypic analysis of the tumor cells grown in vitro before mouse passage, grown in nude mouse, and grown in vitro after mouse passage indicated chromosomal identity and consistent marker chromosomes: three large acrocentric chromosomes and metacentric minute chromosomes.

Entities:  

Mesh:

Year:  1977        PMID: 908039

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.

Authors:  Dazhi Yang; Noemi Kedei; Luowei Li; Juan Tao; Julia F Velasquez; Aleksandra M Michalowski; Balázs I Tóth; Rita Marincsák; Attila Varga; Tamás Bíró; Stuart H Yuspa; Peter M Blumberg
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

2.  Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Ralph Tuthill; Lili Liu; Stanton Gerson; Ernest Borden; Taolin Yi
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

Review 3.  Cholesterol as a potential target for castration-resistant prostate cancer.

Authors:  Alexis L Twiddy; Carlos G Leon; Kishor M Wasan
Journal:  Pharm Res       Date:  2010-08-04       Impact factor: 4.200

4.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

5.  A better defined medium for human prostate cancer cells.

Authors:  T G Pretlow; G S Ogrinc; S B Amini; C M Delmoro; K F Molkentin; J K Willson; T P Pretlow
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

6.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.

Authors:  B B Moore; D A Arenberg; K Stoy; T Morgan; C L Addison; S B Morris; M Glass; C Wilke; Y Y Xue; S Sitterding; S L Kunkel; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.

Authors:  Muthu K Shanmugam; Peramaiyan Rajendran; Feng Li; Tarang Nema; Shireen Vali; Taher Abbasi; Shweta Kapoor; Ashish Sharma; Alan Prem Kumar; Paul C Ho; Kam M Hui; Gautam Sethi
Journal:  J Mol Med (Berl)       Date:  2011-04-05       Impact factor: 4.599

8.  A new human prostate carcinoma cell line, 22Rv1.

Authors:  R M Sramkoski; T G Pretlow; J M Giaconia; T P Pretlow; S Schwartz; M S Sy; S R Marengo; J S Rhim; D Zhang; J W Jacobberger
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

9.  Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.

Authors:  Jongchan Kim; Meejeon Roh; Sarki A Abdulkadir
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

10.  Elevated overall rates of transmethylation in cell lines from diverse human tumors.

Authors:  P H Stern; R M Hoffman
Journal:  In Vitro       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.